p.137 抽出テキスト

手引き.2019.https://www.j-circ.or.jp/old/topics/files/PFO_Closure_Man.pdf 557. Ueno Y, Iguchi Y, Inoue T, et al. Paradoxical brain embolism may not be uncommon-prospective study in acute ischemic stroke. J Neurol 2007; 254: 763-766. PMID: 17380241 558. Furlan AJ, Reisman M, Massaro J, et al. CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012; 366: 991-999. PMID: 22417252 559. Meier B, Kalesan B, Mattle HP, et al. PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013; 368: 1083-1091. PMID: 23514285 560. Carroll JD, Saver JL, Thaler DE, et al. RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013; 368: 1092-1100. PMID: 23514286 561. Pristipino C, Sievert H, D’Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J 2019; 40: 3182-3195. PMID: 30358849 562. Nakayama R, Takaya Y, Akagi T, et al. Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System. J Am Soc Echocardiogr 2019; 32: 811- 816. PMID: 31130417 563. 日本循環器学会.肺血栓塞栓症および深部静脈血栓症の診断,治療,予防に関するガイドライン(2017年改訂版).https:// www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf 564. Ando T, Holmes AA, Pahuja M, et al. Meta-Analysis Comparing Patent Foramen Ovale Closure Versus Medical Therapy to Prevent Recurrent Cryptogenic Stroke. Am J Cardiol 2018; 121: 649-655. PMID: 29306484 565. Vaduganathan M, Qamar A, Gupta A, et al. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Am J Med 2018; 131: 575-577. PMID: 29229471 566. Mojadidi MK, Elgendy AY, Elgendy IY, et al. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv 2017; 10: 2228-2230. PMID: 29122137 567. 日本循環器学会,日本不整脈心電学会.2020年改訂版不整脈薬物治療ガイドライン.https://www.j-circ.or.jp/cms/wp-content/uploads/2020/01/JCS2020_Ono.pdf 568. 日本脳卒中学会.脳卒中治療ガイドライン2015〔追補2019〕. https://www.jsts.gr.jp/img/guideline2015_tuiho2019_10.pdf 569. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996; 61: 755-759. PMID: 8572814 570. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 2002; 105: 1887-1889. PMID: 11997272 571. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 2019; 140: e125-e151. PMID: 30686041 572. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2893-2962. PMID: 27567408 573. Lee R, Jivan A, Kruse J, et al. Late neurologic events after surgery for atrial fibrillation: rare but relevant. Ann Thorac Surg 2013; 95: 126-132. PMID: 23063202 574. Kanderian AS, Gillinov AM, Pettersson GB, et al. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 2008; 52: 924-929. PMID: 18772063 575. Holmes DR, Reddy VY, Turi ZG, et al. PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009; 374: 534-542. PMID: 19683639 576. Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014; 64: 1-12. PMID: 24998121 577. Reddy VY, Doshi SK, Kar S, et al. PREVAIL and PROTECT AF Investigators. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol 2017; 70: 2964-2975. PMID: 29103847 578. Reddy VY, Gibson DN, Kar S, et al. Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. J Am Coll Cardiol 2017; 69: 253-261. PMID: 27816552 578a. 日本循環器学会.左心耳閉鎖システムに関する適正使用指針. http://www.j-circ.or.jp/WatchMan/wm_tekisei_shishin.pdf 579. Friedman DJ, Piccini JP, Wang T, et al. Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery. JAMA 2018; 319: 365-374. PMID: 29362794 580. Melduni RM, Schaff HV, Lee HC, et al. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 Patients. Circulation 2017; 135: 366-378. PMID: 27903589 581. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2017; 38: 2739-2791. PMID: 28886619 582. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135: e1159-e1195. PMID: 28298458 583. deleted in proof 584. Attizzani GF, Patel SM, Dangas GD, et al. Comparison of Local Versus General Anesthesia Following Transfemoral Transcatheter Self-Expanding Aortic Valve Implantation (from the Transcatheter Valve Therapeutics Registry). Am J Cardiol 2019; 123: 419-425. PMID: 30527797 585. Hosoba S, Yamamoto M, Shioda K, et al. Safety and efficacy of minimalist approach in transfemoral transcatheter aortic valve replacement: insights from the Optimized transCathEter vAlvular interventioN-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry. Interact Cardiovasc Thorac Surg 2018; 26: 420-424. PMID: 29096029 585a. 経カテーテル的心臓弁治療関連学会協議会.経カテーテル的大動脈弁置換術実施施設基準.http://j-tavr.com/guideline.html 586. Maeda K, Kuratani T, Mizote I, et al. Early experiences of transcatheter aortic valve replacement in Japan. Circ J 2013; 77: 359-362. PMID: 23064398 587. Wendler O, Schymik G, Treede H, et al. SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve. Circulation 2017; 135: 1123-1132. PMID: 28104716 588. Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2020; 76: 2492-2516. PMID: 33213729 589. Mack MJ, Brennan JM, Brindis R, et al. STS/ACC TVT Registry. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013; 310: 2069-2077. PMID: 24240934 590. Beurtheret S, Karam N, Resseguier N, et al. Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2019; 74: 2728-2739. PMID: 31779788 591. Young MN, Singh V, Sakhuja R. A Review of Alternative Access for Transcatheter Aortic Valve Replacement. Curr Treat Options Cardiovasc Med 2018; 20: 62. PMID: 29974264 592. Overtchouk P, Modine T. Alternate Access for TAVI: Stay Clear of the Chest. Interv Cardiol 2018; 13: 145-150. PMID: 30443273 593. Blackstone EH, Suri RM, Rajeswaran J, et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation 2015; 131: 1989-2000. PMID: 25832034 594. Svensson LG, Blackstone EH, Rajeswaran J, et al. PARTNER Trial Investigators. Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. J Am Coll Cardiol 2014; 64: 158-168. PMID: 25011720 595. Doshi R, Shah P, Meraj PM. In-hospital outcomes comparison of transfemoral vs transapical transcatheter aortic valve replacement in propensity-matched cohorts with severe aortic stenosis. Clin Cardiol 2018; 41: 326-332. PMID: 29573452 596. Blanke P, Weir-McCall JR, Achenbach S, et al. Computed Tomogra-